CAROLYN EVANCHO: Open Payments
NPI 1134678477 · BROOMALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 96 payments from 16 companies in 2025. Trend: 2023 $2,032 · 2024 $1,959 · 2025 $1,815
Food & beverage: $1,815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $530 |
| Ardelyx, Inc. | 12 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $164 |
| GENZYME CORPORATION | 7 | $164 |
| Madrigal Pharmaceuticals | 5 | $135 |
| Ipsen Biopharmaceuticals, Inc | 4 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Novo Nordisk Inc | 3 | $84 |
| Daiichi Sankyo Inc. | 2 | $60 |
Products named: RINVOQ, DUPIXENT, IBSRELA, XIFAXAN, REZDIFFRA, IQIRVO, Wegovy, ENTYVIO.
Industry payments across PA — which companies pay providers there.
